Jeffrey A. Allen, D. Gelinas, R. Lewis, R. Nowak, G. Wolfe
{"title":"优化慢性炎症性脱髓鞘性多神经病变预后指标的使用","authors":"Jeffrey A. Allen, D. Gelinas, R. Lewis, R. Nowak, G. Wolfe","doi":"10.17925/USN.2017.13.01.26","DOIUrl":null,"url":null,"abstract":"Disclosure: Jeffrey A Allen is a consultant for, and has received clinical trial support, from: Axelacare, CSL Behring, and Grifols. Deborah F Gelinas is an employee of Grifols, and is on the Avanir Speaker Bureau for Nuedexta. Richard A Lewis is a consultant for Axelacare, CSL Behring, Biotest Pharma, Kedrion, and Pharnext. Richard J Nowak is a speaker and advisor/consultant for Grifols. Gil I Wolfe participated in Shire and Grifols advisory boards and received research support from CSL Behring.","PeriodicalId":12047,"journal":{"name":"European neurological review","volume":"13 1","pages":"26-33"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Optimizing the use of outcome measures in chronic inflammatory demyelinating polyneuropathy\",\"authors\":\"Jeffrey A. Allen, D. Gelinas, R. Lewis, R. Nowak, G. Wolfe\",\"doi\":\"10.17925/USN.2017.13.01.26\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Disclosure: Jeffrey A Allen is a consultant for, and has received clinical trial support, from: Axelacare, CSL Behring, and Grifols. Deborah F Gelinas is an employee of Grifols, and is on the Avanir Speaker Bureau for Nuedexta. Richard A Lewis is a consultant for Axelacare, CSL Behring, Biotest Pharma, Kedrion, and Pharnext. Richard J Nowak is a speaker and advisor/consultant for Grifols. Gil I Wolfe participated in Shire and Grifols advisory boards and received research support from CSL Behring.\",\"PeriodicalId\":12047,\"journal\":{\"name\":\"European neurological review\",\"volume\":\"13 1\",\"pages\":\"26-33\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European neurological review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17925/USN.2017.13.01.26\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European neurological review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/USN.2017.13.01.26","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 9
摘要
披露:Jeffrey A Allen是Axelacare、CSL Behring和Grifols的临床试验顾问，并获得了这些公司的支持。黛博拉·F·吉利纳斯是Grifols的一名员工，也是Nuedexta Avanir Speaker Bureau的一员。Richard A . Lewis是Axelacare、CSL Behring、Biotest Pharma、Kedrion和Pharnext的顾问。理查德·J·诺瓦克(Richard J Nowak)是Grifols的演讲者和顾问。Gil I Wolfe参加了Shire和Grifols顾问委员会，并获得了CSL Behring的研究支持。
Optimizing the use of outcome measures in chronic inflammatory demyelinating polyneuropathy
Disclosure: Jeffrey A Allen is a consultant for, and has received clinical trial support, from: Axelacare, CSL Behring, and Grifols. Deborah F Gelinas is an employee of Grifols, and is on the Avanir Speaker Bureau for Nuedexta. Richard A Lewis is a consultant for Axelacare, CSL Behring, Biotest Pharma, Kedrion, and Pharnext. Richard J Nowak is a speaker and advisor/consultant for Grifols. Gil I Wolfe participated in Shire and Grifols advisory boards and received research support from CSL Behring.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
